These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics.
    Author: Watine J, Bourrel C, Dubourdieu B, Gineston JL, Bories P, Durand M, Marre A, Formosa F, Brunel MP, Palliez J.
    Journal: Pathol Biol (Paris); 1994 Apr; 42(4):293-5. PubMed ID: 7808781.
    Abstract:
    Serotype 012 represented 15% of 244 isolates of Pseudomonas aeruginosa isolated in the hospital over a 2 year-period and most isolates of this serotype were resistant to multiple antibiotics. Combination experiments showed that fosfomycin and amikacin together were active against 92% of 012 isolates. It is recommended that serotyping be used systematically to identify 012 strains rapidly and fosfomycin/amikacin be considered as a presumptive antipseudomonal therapy in 012 infections.
    [Abstract] [Full Text] [Related] [New Search]